STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
69 hedge funds and large institutions have $166M invested in Stemline Therapeutics, Inc. in 2015 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
11% more funds holding
Funds holding: 62 → 69 (+7)
Holders
69
Holding in Top 10
–
Calls
$524K
Puts
$103K
Top Buyers
| 1 | +$8.36M | |
| 2 | +$6.88M | |
| 3 | +$6.87M | |
| 4 |
TCM
TimesSquare Capital Management
New York
|
+$6.82M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$5.06M |
Top Sellers
| 1 | -$2.55M | |
| 2 | -$406K | |
| 3 | -$364K | |
| 4 |
Goldman Sachs
New York
|
-$285K |
| 5 |
CIA
Capital Impact Advisors
Boston,
Massachusetts
|
-$173K |